October 5, 2009
Australian Full Federal Court Holds Sanofi Enantiomer Patent Invalid
In August 2007, Apotex applied to the Federal Court of Australia for an order revoking Australian Patent No. 597784 in the name of sanofi-aventis, which covers clopidogrel and its pharmaceutically acceptable salts (the Clopidogrel Patent). In August 2008, the Federal Court found that a number of the claims in the Clopidogrel Patent were invalid, but did not invalidate...